0001062993-23-014992.txt : 20230718
0001062993-23-014992.hdr.sgml : 20230718
20230718161331
ACCESSION NUMBER: 0001062993-23-014992
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230717
FILED AS OF DATE: 20230718
DATE AS OF CHANGE: 20230718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clayton Russell
CENTRAL INDEX KEY: 0001530072
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36510
FILM NUMBER: 231094396
MAIL ADDRESS:
STREET 1: 2600 KELLY RD
CITY: WARRINGTON
STATE: PA
ZIP: 18976
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Larimar Therapeutics, Inc.
CENTRAL INDEX KEY: 0001374690
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203857670
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: THREE BALA PLAZA EAST. SUITE 506
CITY: BALA CYNWYD
STATE: PA
ZIP: 19004
BUSINESS PHONE: 844-511-9056
MAIL ADDRESS:
STREET 1: THREE BALA PLAZA EAST. SUITE 506
CITY: BALA CYNWYD
STATE: PA
ZIP: 19004
FORMER COMPANY:
FORMER CONFORMED NAME: ZAFGEN, INC.
DATE OF NAME CHANGE: 20100301
FORMER COMPANY:
FORMER CONFORMED NAME: ZAFGEN INC
DATE OF NAME CHANGE: 20060906
3
1
form3.xml
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
X0206
3
2023-07-17
1
0001374690
Larimar Therapeutics, Inc.
LRMR
0001530072
Clayton Russell
C/O LARIMAR THERAPEUTICS, INC.
THREE BALA PLAZA EAST, SUITE 506
BALA CYNWYD
PA
19004
0
1
0
0
Chief Medical Officer
Exhibit List - Exhibit 24 - Power of Attorney
/s/ Jennifer Johansson, Attorney-in-fact
2023-07-18
EX-24.1
2
exhibit24-1.txt
POA
LIMITED POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS, that the undersigned
hereby constitutes and appoints the Vice President of Regulatory
Affairs and Counsel and Chief Financial Officer of Larimar
Therapeutics, Inc. (the "Company") with full power to act singly,
as the undersigned's true and lawful attorneys-in-fact, with full
power of substitution, to:
1) execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer and/or director and/or
beneficial owner of the Company, Forms 3, 4, and 5 in accordance
with Section 16(a) of the Securities Exchange Act of 1934, as
amended, and the rules thereunder;
2) do and perform any and all acts for and on behalf of
the undersigned which may be necessary or desirable to complete
and execute any such Form 3, 4, or 5, complete and execute any
amendment or amendments thereto, and timely file such form with
the United States Securities and Exchange Commission and any
stock exchange or similar authority; and
3) take any other action of any type whatsoever in
connection with the foregoing which, in the opinion of such
attorney-in-fact, may be of benefit to, in the best interest of,
or legally required by, the undersigned, it being understood
that the documents executed by such attorney-in-fact on behalf
of the undersigned pursuant to this Power of Attorney shall be
in such form and shall contain such terms and conditions as such
attorney-in-fact may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to the attorneys-in-fact
full power and authority to do and perform any and every act and
thing whatsoever requisite, necessary or proper to be done in the
exercise of any of the rights and powers herein granted, as fully
to all intents and purposes as the undersigned might or could do if
personally present with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact or
such attorney-in-fact's substitute or substitutes, shall lawfully
do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted.
This power of attorney shall remain in full force and
effect until revoked by the undersigned in a signed writing
delivered to the attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused
this Power of Attorney to be executed as of this 14th day of
July, 2023.
By: /s/ Russell G. Clayton
Name: Russell G. Clayton, DO
Title: Chief Medical Officer